The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients

Cellular Immunology

Volumn 237, Issue 2, 2005, Pages 96-105

  Nikolova, Maria H ^a   Muhtarova, Maria N ^a   Taskov, Hristo B ^a   Kostov, Kostadin ^b   Vezenkov, Ljubomir ^c   Mihova, Antoaneta ^a   Boumsell, Laurence ^d   Bensussan, Armand ^d  

^a NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^b Infectious Diseases Hospital   (Bulgaria)

^c UNIVERSITY OF CHEMICAL TECHNOLOGY AND METALLURGY   (Bulgaria)

^d FACULTÉ DE MÉDECINE   (France)

Author keywords

Co stimulation; Cytotoxicity; HAART; HIV; Human T cell receptors

Indexed keywords

GAMMA INTERFERON; GRANZYME B; PROTEIN P17; CD160 PROTEIN, HUMAN; EPITOPE; GAG PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; SL9 PEPTIDE;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXIC T LYMPHOCYTE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMOBILIZED CELL; IMMUNE RESPONSE; MALE; MEMORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VIRUS LOAD; CASE CONTROL STUDY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; FEMALE; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 30944462931     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.01.012     Document Type: Article

References (48)

1. + T cell differentiation in response to viruses Nat. Immunol. 3 2003 931 939
2. L. Musey, J. Hughes, T. Schacker, T. Shea, L. Corey, and M.J. McElrath Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection N. Engl. J. Med. 337 1997 1267 1274
3. S.L. Rowland-Jones, T. Dong, K.R. Fowke, J. Kimani, P. Krausa, H. Newell, T. Blanchard, K. Ariyoshi, J. Oyugi, E. Ngugi, J. Bwayo, K.S. MacDonald, A.J. McMichael, and F.A. Plummer Cytotoxic T cell response to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi J. Clin. Invest. 102 1998 1758 1765
4. T. Matano, R. Shibata, C. Siemon, M. Connors, H.C. Lane, and M.A. Martin Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques J. Virol. 72 1998 164 169
5. + lymphocytes Science 283 1999 857 860
6. + cells Virology 225 1996 248 253
7. + cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication Adv. Immunol. 66 1997 273 311
8. A.J. McMichael, and S.L. Rowland-Jones Cellular immune responses to HIV Nature 410 2001 980 987
9. O.O. Yang Will we be able to 'spot' an effective HIV-1 vaccine? Trends Immunol. 24 2003 67 72
10. C. Brander, and B. Walker T lymphocyte responses in HIV-1 infection: implications for vaccine development Curr. Opin. Immunol. 11 1999 451 459
11. G.J. Nabel Challenges and opportunities for development of an AIDS vaccine Nature 410 2001 1002 1007
12. - T lymphocytes. Antigenic and functional properties J. Immunol. 150 1993 1147 1159
13. + T-cell maturation: CD27 might provide a clue Trends Immunol. 23 2002 586 591
14. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
15. + T cells J. Exp. Med. 186 1997 1407 1418
16. M. Merkenschlager, and P.C. Beverley Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTL selectively express CD45RO (UCHL1) Int. Immunol. 4 1989 450 459
17. + T cells closely correlates with CD56 surface expression J. Immunol. 164 2000 1148 1152
18. + T-cell population Immunology 98 1999 443 449
19. + T cells Blood 101 2003 2711 2720
20. + effector alpha beta T cells J. Immunol. 167 2001 6165 6170
21. - human T cells J. Immunol. 165 2000 1910 1917
22. + T cells J. Immunol. 168 2002 2225 2232
23. G. Muller, and M. Lipp Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking Microcirculation 10 2003 325 334
24. A. Bensussan, E. Gluckman, S. El Marsafy, V. Schiavon, I.-G. Mansur, J. Dausset, L. Boumsell, and E.D. Carosella BY55 mAb delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity Proc. Natl. Acad. Sci. USA 91 1994 9136 9140
25. A. Anumanthan, A. Bensussan, L. Boumsell, A.D. Christ, R.S. Blumberg, S.D. Voss, A.T. Patel, M.J. Robertson, L.M. Nadler, and G.J. Freeman Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL and intestinal intraepithelial lymphocytes J. Immunol. 161 1998 2780 2790
26. high T cell compartment: a tri-color analysis of normal peripheral blood lymphocytes, in: D. Mason, P. Andre, A. Bensussan, C. Bucckley, C. Civin, E. Clark, M. De Haas, S. Goyert, M. Hadam, D. Haart, V. Horejsi, Y. Jones, S. Meuer, J. Morrissey, R. Schwartz-Albiez, S. Shaw, D. Simmons, L. Turni, M. Uguccioni, E. van der Schoot, E. Vivier, H. Zola (Eds.), Leucocyte Typing VII, White Cell Differentiation Antigens, Oxford University Press, Oxford, 2002, pp. 683-686.
27. H. Tomiyama, T. Matsuda, and M. Takiguchi Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype J. Immunol. 168 2002 5538 5550
28. S. Agrawal, J. Marquet, G.J. Freeman, A. Tawab, P. Le Bouteiller, P. Roth, W. Bolton, G. Ogg, L. Boumsell, and A. Bensussan Cutting edge: MHC class I triggering by a novel cell surface ligand co-stimulates proliferation of activated human T cells J. Immunol. 162 1999 1223 1226
29. M. Nikolova, A. Marie-Cardine, L. Boumsell, and A. Bensussan BY55/CD160 is a co-receptor in TCR signal transduction of human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression Int. Immunol. 14 2002 445 451
30. + PBL mediating CTL activity Proc. Natl. Acad. Sci. USA 90 1993 9427 9430
31. NCCLS, How to define and determine reference intervals in the clinical laboratory? Approved Guideline, second ed., NCCLS document C28-A2 [ISBN 1-56238-406-6], NCCLS, PN 19087-1898, USA, 2000.
32. + T lymphocyte subpopulations in the course of long term highly active antiretroviral therapy for HIV-1 infection Clin. Appl. Immunol. 2 2003 181 188
33. G.B. Fields, and R.L. Noble Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids Int. J. Pept. Protein Res. 35 1990 161 174
34. E. Wood, R.S. Hogg, B. Yip, P.R. Harrigan, M.V. O'Shaughnessy, and J.S. Montaner The impact of adherence on CD4 cell count responses among HIV-infected patients J. Acquir. Immune Defic. Syndr. 35 2004 261 268
35. U.B. Dragsted, A. Mocroft, S. Vella, J.P. Viard, A.B. Hansen, G. Panos, D. Mercey, L. Machala, A. Horban, and J.D. Lundgren EuroSIDA study group, Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study J. Infect. Dis. 190 2004 148 155
36. C.J. Smith, C.A. Sabin, M.S. Youle, S. Kinloch-de Loes, F.C. Lampe, S. Madge, I. Cropley, M.A. Johnson, and A.N. Phillips Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy J. Infect. Dis. 190 2004 1860 1888
37. M. Roederer, S.C. De Rosa, N. Watanabe, and L.A. Herzenberg Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation Semin. Immunol. 9 1997 389 396
38. + CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection AIDS 13 1999 891 899
39. D.R. Nelson, C.G. Marousis, T. Ohno, G.L. Davis, and J.Y.N. Lau Intrahepatic Hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alpha therapy in chronic hepatitis C Hepatology 28 1998 225 230
40. P. Portales, J. Reynes, R. Rouzier-Panis, V. Baillat, J. Clot, and P. Corbeau Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection AIDS 17 2003 505 511
41. + T cells produce antiviral cytokines but are impaired in cytolytic function J. Exp. Med. 192 2000 63 75
42. + T cells vary in differentiation phenotype in different persistent virus infections Nat. Med. 8 2002 379 385
43. A. Barakonyi, M. Rabot, A. Marie-Cardine, M. Aguerre-Girr, B. Polgar, V. Schiavon, A. Bensussan, and P. Le Bouteiller Cutting edge: Engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset J. Immunol. 173 2004 5349 5354
44. K.L. Collins, B.K. Chen, S.A. Kalams, B.D. Walker, and D. Baltimore HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes Nature 391 1998 397 401
45. M. Williams, J.F. Roeth, M.R. Kasper, R.I. Fleis, C.G. Przybycin, and K.L. Collins Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking J. Virol. 76 2002 12173 12184
46. M.D. Galiani, E. Aguado, R. Tarazona, P. Romero, I. Molina, M. Santamaria, R. Solana, and J. Pena Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals Clin. Exp. Immunol. 115 1999 472 476
47. M.C. Sirianni, F. Ensoli, C. Alario, V. Fiorelli, G. Sacco, S. Topino, F. Iebba, I. Mezzaroma, and F. Aiuti Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection Hum. Immunol. 62 2001 1328 1334
48. - cells with ageing Clin. Exp. Immunol. 112 1998 48 51